Welcome to our dedicated page for Moelis & Co SEC filings (Ticker: MC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles Moelis & Company (NYSE: MC) SEC filings, giving investors structured access to the firm’s regulatory disclosures as a global independent investment bank in the investment banking and securities dealing industry. Filings such as Form 8-K, Form 10-K, Form 10-Q, and Form 4 provide insight into Moelis & Company’s financial performance, governance, and insider activity.
Moelis & Company uses Current Reports on Form 8-K to announce material events, including quarterly financial results and board changes. For example, the company files 8-Ks when it releases earnings for specific quarters and when its Board elects a new independent director, detailing items such as results of operations, updated investor presentations, and director compensation arrangements.
Investors can look to the firm’s annual reports on Form 10-K and quarterly reports on Form 10-Q (when available on this page) for more comprehensive information on revenues, expenses, net income, segment drivers, and risk factors. Moelis & Company also discusses its use of Adjusted (non-GAAP) metrics in conjunction with GAAP results, and its filings reference the ownership structure of Moelis & Company Group LP and related tax treatment.
In addition, Form 4 insider transaction reports, when present, can help users track purchases, sales, and equity awards involving Moelis & Company’s directors and executive officers. Proxy-related filings may further describe board composition, director independence, and compensation practices, as illustrated by the firm’s disclosure of compensation for an independent director in a Form 8-K.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, explain complex sections in simpler language, and surface notable items such as changes in revenues, margins, dividends, or governance. With real-time updates from EDGAR and organized access to 10-Ks, 10-Qs, 8-Ks, and Form 4s, this page helps users quickly understand what Moelis & Company is reporting to regulators and how those disclosures relate to its advisory-focused business model.
Shropshire Kenneth reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Kenneth Shropshire reported routine equity compensation grants. On March 26, 2026, he received 2024 Annual Restricted Stock Units, 2025 Annual Restricted Stock Units, and 2025 Elective Restricted Stock Units as awards recorded at a price of $0.00 per unit.
Each Restricted Stock Unit represents the right to receive one share of Class A Common Stock. These 2024 and 2025 Annual RSUs and 2025 Elective RSUs were issued as dividend equivalents on previously granted underlying RSUs and will vest at the same time as the corresponding underlying awards.
Worrell Laila reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Laila Worrell reported awards of additional restricted stock units tied to prior equity grants. On March 26, 2026, she received 24.05 2024 Annual RSUs, 20.07 2025 Annual RSUs, and 10.99 2025 Elective RSUs, all at a stated price of $0.00 per unit as compensation.
Each RSU represents the right to receive one share of Moelis Class A common stock. These RSUs were issued as dividend equivalents on the related underlying RSU awards and will vest at the same time as those underlying awards. Following these grants, Worrell’s reported holdings in these RSU series are 2,075.39, 1,731.70, and 948.78 units, respectively, with no sales reported in this filing.
Cantor Eric reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Company director and vice chairman Eric Cantor reported compensation-related equity grants rather than market trades. On March 26, he was awarded multiple Incentive RSUs and Long Term Incentive RSUs that function as dividend equivalents on his existing unvested RSU awards.
Each Restricted Stock Unit represents a right to receive either a share of Class A common stock or cash equal to its fair market value upon settlement. These dividend-equivalent RSUs will vest on the same schedule as the underlying Incentive and Long Term Incentive RSUs issued between February 2022 and February 2025, and no open‑market purchases or sales were reported.
Riehl Nick reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co Principal Accounting Officer Nick Riehl reported receiving five small grants of dividend-equivalent Restricted Stock Units (RSUs) tied to existing incentive awards. In total, he was granted 36.8 RSUs that each represent the right to receive either a share of Class A common stock or cash equal to its market value upon settlement.
The RSUs relate to prior Incentive and Long Term Incentive RSUs issued in February 2024 and February 2025, as well as Incentive and Special Incentive RSUs issued in February 2026. These dividend-equivalent RSUs will vest on the same schedule as the underlying unvested RSUs, reflecting routine compensation rather than any open-market stock purchases or sales.
Moelis & Company Chief Financial Officer Christopher Callesano reported routine compensation-related awards of Incentive Restricted Stock Units (RSUs). On March 26, 2026, he acquired 4.5000 2021 Incentive RSUs, 14.1900 2022 Incentive RSUs, 14.6200 2023 Incentive RSUs, and 15.5600 2024 Incentive RSUs, all at a grant price of $0.0000 per unit.
Each RSU represents the right, upon settlement, to receive either one share of Class A common stock or cash equal to its fair market value, at the company’s option. The footnotes explain these Incentive RSUs were issued as dividend equivalents on previously granted unvested Incentive RSUs and will vest on the same schedule as those underlying awards. These are non-market, compensation grants rather than open-market purchases or sales.
Pilcher Ciafone Katherine reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co Chief Operating Officer Katherine Pilcher Ciafone received additional incentive RSUs as part of her equity compensation. On March 26, she was granted 16.48 RSUs linked to 2021 incentives and 46.89 RSUs linked to 2022 incentives, each convertible into an equivalent number of Class A common shares or cash at the company’s option.
The footnotes state these incentive RSUs were issued as dividend equivalents on her existing unvested incentive RSUs granted in February 2022 and February 2023. The dividend-equivalent RSUs will vest on the same schedule as the underlying unvested incentive RSUs, reflecting routine compensation rather than open-market buying or selling.
WATANABE OSAMU R. reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co reported that General Counsel and Secretary Osamu R. Watanabe received additional restricted stock units as compensation. On March 26, 2026, he was granted an aggregate of roughly 275.10 dividend-equivalent Incentive and Special Incentive RSUs, each linked to existing unvested awards.
Each RSU entitles the holder, upon settlement, to either one share of Class A common stock or cash equal to that share’s fair market value, at the company’s option. These grants vest on the same schedule as the underlying unvested Incentive RSUs and represent routine equity-based compensation rather than open-market stock purchases or sales.
Barker Thorold reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Barker Thorold received a grant of 19.11 2025 Annual Restricted Stock Units on Class A Common Stock. The grant was reported at a price of $0.00 per unit as a compensation-related award, not an open-market trade. Following this award, Thorold directly holds 1,649.29 shares, including the new RSUs, which were issued as dividend equivalents that will vest at the same time as the underlying Annual RSUs.
Mirrer Louise reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Louise Mirrer received additional stock-based compensation in the form of restricted stock units. On March 26, 2026, she was granted 20.07 "2025 Annual" RSUs and two "2024 Annual" RSU dividend-equivalent grants of 14.84 and 0.46 units.
Each RSU represents the right to receive one share of Moelis & Co Class A common stock. The 2024 and 2025 Annual RSUs were issued as dividend equivalents and will vest at the same time as the related underlying Annual RSU awards issued in 2024 and 2025. After these grants, reported holdings for these RSU awards are 1,731.7, 1,280.4 and 39.6 units, respectively.
The Vanguard Group filed Amendment No. 10 to Schedule 13G/A reporting 0 shares and 0% beneficial ownership of Moelis & Co common stock. The filing explains an internal realignment effective January 12, 2026, that caused certain Vanguard subsidiaries or business divisions to report holdings separately in reliance on SEC Release No. 34-39538.
The amendment lists voting and dispositive powers as 0 and states that no single outside person holds more than 5% of the class. The form is signed by Ashley Grim as Head of Global Fund Administration.